Glipmevia 50/500Mg 30’S

Glipmevia 50/500mg 30's - Dual Action Diabetes Management | Glimepiride and Metformin Combination

Glipmevia 50/500mg is a combination medication used to manage type 2 diabetes by helping control blood sugar levels. This product contains Glimepiride, a sulfonylurea, and Metformin, a biguanide, working together to provide dual-action control. Glimepiride stimulates the pancreas to produce more insulin, while Metformin reduces glucose production in the liver and enhances the body’s sensitivity to insulin.

This combination therapy is ideal for patients whose blood sugar is not adequately controlled by diet and exercise alone. Glipmevia 50/500mg provides a balanced and effective approach to managing blood sugar, helping patients reduce their risk of diabetes-related complications such as cardiovascular disease and kidney problems.

How to Use Glipmevia 50/500mg 30's

Take one Glipmevia 50/500mg tablet once or twice daily, preferably with meals to reduce stomach upset. Always follow the dosing instructions provided by your doctor, as the dose may vary based on individual needs and treatment response.

Precautions

Before starting Glipmevia, inform your healthcare provider if you have a history of kidney disease, liver disease, or heart problems. This medication is not recommended during pregnancy and should only be used with caution while breastfeeding.

Possible Side Effects

Side effects may include low blood sugar (hypoglycemia), nausea, diarrhea, dizziness, and weight gain. Rare but serious side effects may include lactic acidosis, severe hypoglycemia, and liver problems. Seek medical help immediately if you experience symptoms such as unusual tiredness, muscle pain, or difficulty breathing.